Analyst Comparison Highlights Valuation and Risk Between Mirum Pharmaceuticals and United…
What happened
A comparison of Mirum Pharmaceuticals and United Therapeutics found that United Therapeutics generates higher gross revenue and earnings per share than Mirum Pharmaceuticals. However, Mirum Pharmaceuticals trades at a lower price-to-earnings ratio, suggesting it is currently more affordable. Analysts also noted that Mirum Pharmaceuticals has a stronger consensus rating and a higher potential upside.
From themarketsdaily.com
Why it matters
The comparison highlights differing risk and valuation profiles between the two healthcare companies. Mirum Pharmaceuticals is noted as being less volatile than the S&P 500, with a beta of 0.61, while United Therapeutics has a beta of 0.49. These metrics influence market perception of investment risk.
From themarketsdaily.com
Who's involved
- Mirum PharmaceuticalsBiopharmaceutical company compared against United Therapeutics
- United TherapeuticsBiotech company compared against Mirum Pharmaceuticals
Keep exploring
The entities involved
-
Mirum Pharmaceuticals
biopharmaceutical company
Nothing else this week.
-
United Therapeutics
biotech company based in Silver Spring, Maryland, United States